Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GBT | HALO | CRSP | ||
| Company | Global Blood Ther | Halozyme Therapeutic | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 68.48 | 38.46 | 54.21 | ||
| High | 68.49 | 39.02 | 54.94 | ||
| Low | 68.47 | 38.46 | 52.81 | ||
| Last | 68.49 | 38.57 | 53.91 | ||
| Change | +0.01 | +0.11 | +0.18 | ||
| % Change | +0.01% | +0.29% | +0.34% | ||
| Volume | 3,279,900 | 547,100 | 1,353,500 | ||
| 20-Day Average Volume | 2,771,555 | 865,375 | 1,300,950 | ||
| Previous Close | 68.48 | 38.46 | 53.73 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 67.97 | 39.27 | 59.96 | ||
| 20-Day Raw Stochastic | 100.00% | 21.71% | 7.42% | ||
| 20-Day Relative Strength | 79.23% | 46.38% | 31.16% | ||
| Weighted Alpha | +51.60 | +14.88 | -14.93 | ||
| Today's Opinion | 100% Buy | 8% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.45% since 09/27/22 | -0.18% since 04/19/24 | -2.07% since 04/19/24 | ||
| Low | 67.79 on 09/29/22 | 38.23 on 04/25/24 | 52.75 on 04/25/24 | ||
| High | 68.49 on 10/04/22 | 39.70 on 04/24/24 | 58.67 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +1.02% since 09/02/22 | -3.77% since 03/26/24 | -24.04% since 03/26/24 | ||
| Low | 67.54 on 09/16/22 | 37.73 on 04/19/24 | 52.75 on 04/25/24 | ||
| High | 68.49 on 10/04/22 | 41.60 on 04/01/24 | 71.54 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | +108.81% since 07/01/22 | +12.74% since 01/26/24 | -11.64% since 01/26/24 | ||
| Low | 31.51 on 08/01/22 | 33.15 on 02/05/24 | 52.75 on 04/25/24 | ||
| High | 73.02 on 08/05/22 | 42.64 on 03/13/24 | 91.10 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | +83.62% since 04/04/22 | +11.51% since 10/26/23 | +37.84% since 10/26/23 | ||
| Low | 21.65 on 06/13/22 | 33.07 on 10/31/23 | 38.16 on 10/30/23 | ||
| High | 73.02 on 08/05/22 | 42.82 on 12/14/23 | 91.10 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,621,431 | 4,900,473 | 4,576,043 | ||
| Shares Outstanding, K | 67,476 | 127,054 | 84,883 | ||
| Annual Sales | 194,750,000 | 829,250,000 | 371,210,000 | ||
| Annual Net Income | -303,090,000 | 281,590,000 | -153,610,000 | ||
| Last Quarter Sales | 71,550,000 | 230,040,000 | 201,210,000 | ||
| Last Quarter Net Income | -82,470,000 | 85,390,000 | 89,350,000 | ||
| 60-Month Beta | 0.45 | 1.25 | 1.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 08/08/22 | 0.82 on 02/20/24 | 1.10 on 02/21/24 | ||
| Latest Earnings Date | 11/03/22 | 05/07/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 0.00 | ||